| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/17/2023 | PERRIGO Co plc | PRGO | Exercise | Restricted Stock Units | 7.8k | $0.00 | $0 | | 05/17/2023 |
| 05/17/2023 | PERRIGO Co plc | PRGO | Payment of Exercise | Ordinary Shares | 3.7k | $32.86 | $122.7k | | 05/17/2023 |
| 05/17/2023 | PERRIGO Co plc | PRGO | Exercise | Ordinary Shares | 7.8k | $32.86 | $255.6k | | 05/17/2023 |
| 05/15/2023 | PERRIGO Co plc | PRGO | Grant | Restricted Stock Units | 8.8k | $0.00 | $0 | | 05/15/2023 |
| 05/02/2023 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 9.1k | $0.00 | $0 | | 05/02/2023 |
| 05/02/2023 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 22k | $10.95 | $241.4k | | 05/02/2023 |
| 11/22/2022 | Theravance Biopharma, Inc. | TBPH | Disposition | Ordinary Shares | 10k | $10.50 | $105k | | 11/22/2022 |
| 04/26/2022 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 9.9k | $0.00 | $0 | | 04/26/2022 |
| 04/26/2022 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 28k | $10.15 | $284.2k | | 04/26/2022 |
| 05/17/2021 | PERRIGO Co plc | PRGO | Grant | Restricted Stock Units | 6.6k | $0.00 | $0 | | 05/17/2021 |
| 05/07/2021 | PERRIGO Co plc | PRGO | Exercise | Restricted Stock Units | 5.8k | $0.00 | $0 | | 05/07/2021 |
| 05/07/2021 | PERRIGO Co plc | PRGO | Payment of Exercise | Ordinary Shares | 2.8k | $42.96 | $119.7k | | 05/07/2021 |
| 05/07/2021 | PERRIGO Co plc | PRGO | Exercise | Ordinary Shares | 5.8k | $42.96 | $249.3k | | 05/07/2021 |
| 04/27/2021 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 9.8k | $0.00 | $0 | | 04/27/2021 |
| 04/27/2021 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $20.35 | $122.1k | | 04/27/2021 |
| 05/15/2020 | PERRIGO Co plc | PRGO | Exercise | Ordinary Shares | 6.1k | $52.76 | $319.4k | | 05/15/2020 |
| 05/15/2020 | PERRIGO Co plc | PRGO | Payment of Exercise | Ordinary Shares | 2.9k | $52.76 | $153.3k | | 05/15/2020 |
| 05/15/2020 | PERRIGO Co plc | PRGO | Exercise | Restricted Stock Units | 6.1k | $0.00 | $0 | | 05/15/2020 |
| 05/07/2020 | PERRIGO Co plc | PRGO | Grant | Restricted Stock Units | 5.8k | $0.00 | $0 | | 05/07/2020 |
| 04/28/2020 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 6.6k | $0.00 | $0 | | 04/28/2020 |
| 04/28/2020 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $30.14 | $180.8k | | 04/28/2020 |
| 05/17/2019 | Theravance Biopharma, Inc. | TBPH | Sale | Ordinary Shares | 2.7k | $20.19 | $54k | | 05/16/2019 |
| 05/16/2019 | Theravance Biopharma, Inc. | TBPH | Sale | Ordinary Shares | 1.3k | $21.00 | $27.9k | | 05/16/2019 |
| 05/15/2019 | PERRIGO Co plc | PRGO | Exercise | Ordinary Shares | 4k | $49.55 | $196.8k | | 05/15/2019 |
| 05/15/2019 | PERRIGO Co plc | PRGO | Payment of Exercise | Ordinary Shares | 1.9k | $49.55 | $94.5k | | 05/15/2019 |
| 05/15/2019 | PERRIGO Co plc | PRGO | Grant | Restricted Stock Units | 6.1k | $0.00 | $0 | | 05/15/2019 |
| 05/15/2019 | PERRIGO Co plc | PRGO | Exercise | Restricted Stock Units | 4k | $0.00 | $0 | | 05/15/2019 |
| 04/30/2019 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $23.85 | $143.1k | | 04/30/2019 |
| 04/30/2019 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 8.4k | $0.00 | $0 | | 04/30/2019 |
| 06/06/2018 | PERRIGO Co plc | PRGO | Exercise | Ordinary Shares | 4.3k | $73.22 | $312.3k | | 06/06/2018 |
| 06/06/2018 | PERRIGO Co plc | PRGO | Payment of Exercise | Ordinary Shares | 2.2k | $73.22 | $162.4k | | 06/06/2018 |
| 06/06/2018 | PERRIGO Co plc | PRGO | Exercise | Restricted Stock Units | 4.3k | $0.00 | $0 | | 06/06/2018 |
| 05/15/2018 | PERRIGO Co plc | PRGO | Grant | Restricted Stock Units | 4k | $0.00 | $0 | | 05/15/2018 |
| 05/01/2018 | Theravance Biopharma, Inc. | TBPH | Grant | Ordinary Shares | 8.2k | $0.00 | $0 | | 05/01/2018 |
| 05/01/2018 | Theravance Biopharma, Inc. | TBPH | Grant | Share Option (Right to Buy) | 6k | $24.43 | $146.6k | | 05/01/2018 |
|